Can a new infusion stop the Body's attack on a transplanted kidney?
Disease control
Not yet recruiting
This trial tests an experimental drug called SG301 in people who have antibody-mediated rejection after a kidney transplant. The goal is to see if the drug is safe and may help control the immune system's attack on the new kidney. Participants receive the drug by infusion weekly …
Phase: PHASE2 • Sponsor: Hangzhou Sumgen Biotech Co., Ltd. • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC